{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:18:42Z","timestamp":1789676322420,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T00:00:00Z","timestamp":1640563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000956","name":"Department of Sport and Recreation, Government of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jsps.2021.12.014","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T02:21:29Z","timestamp":1640917289000},"page":"138-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Metformin attenuates V-domain Ig suppressor of T-cell activation through the aryl hydrocarbon receptor pathway in Melanoma: In Vivo and In Vitro Studies"],"prefix":"10.1007","volume":"30","author":[{"given":"Fawaz E.","family":"Alanazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homood M.","family":"As Sobeai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Alhazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Al-Dhfyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musaad A","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moureq","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Al-hosaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham M.","family":"Korashy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alhoshani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"1","key":"10.1016\/j.jsps.2021.12.014_b0005","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-018-0375-1","article-title":"Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1\/anti-CTLA-4) in metastatic malignant melanoma","volume":"6","author":"Afzal","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jsps.2021.12.014_b0010","article-title":"Aryl hydrocarbon receptor\/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and \u03b2-Catenin and Akt activation","author":"Al-Dhfyan","year":"2017","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.jsps.2021.12.014_b0015","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1016\/j.sjbs.2021.08.051","article-title":"In Vivo and In Vitro Studies Evaluating the Chemopreventive Effect of Metformin on the Aryl Hydrocarbon Receptor-Mediated Breast Carcinogenesis","volume":"28","author":"Alhoshani","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"issue":"10","key":"10.1016\/j.jsps.2021.12.014_b0020","first-page":"7254","article-title":"Fibroblast growth factor 14 modulates the neurogenesis of granule neurons in the adult dentate gyrus","volume":"53","author":"Alshammari","year":"2016","journal-title":"Molecular"},{"key":"10.1016\/j.jsps.2021.12.014_b0025","first-page":"113787","article-title":"Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin","volume":"174","author":"Bahrambeigi","year":"2020","journal-title":"Biochemical"},{"issue":"16","key":"10.1016\/j.jsps.2021.12.014_b0030","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsps.2021.12.014_b0035","article-title":"alpha-Naphthoflavone antagonism of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression","author":"Blank","year":"1987","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jsps.2021.12.014_b0040","article-title":"Preclinical evaluation of LU 79553: a novel bis-naphthalimide with potent antitumor activity","author":"Bousquet","year":"1995","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.jsps.2021.12.014_b0045","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1158\/1535-7163.MCT-12-1226-T","article-title":"Metformin blocks melanoma invasion and metastasis development in AMPK\/p53-dependent manner","volume":"12","author":"Cerezo","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.jsps.2021.12.014_b0050","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","article-title":"Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1","volume":"71","author":"Cha","year":"2018","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.jsps.2021.12.014_b0055","article-title":"The prognostic significance of VISTA and CD33-positive myeloid cells in cutaneous melanoma and their relationship with PD-1 expression","volume":"10","author":"Choi","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jsps.2021.12.014_b0060","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/carcin\/bgq028","article-title":"The aryl hydrocarbon receptor (AhR) in the regulation of cell\u2013cell contact and tumor growth","volume":"31","author":"Dietrich","year":"2010","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.jsps.2021.12.014_b0065","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.taap.2014.07.021","article-title":"Metformin suppresses CYP1A1 and CYP1B1 expression in breast cancer cells by down-regulating aryl hydrocarbon receptor expression","volume":"280","author":"Do","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.jsps.2021.12.014_b0070","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1073\/pnas.1417636112","article-title":"Immune-mediated antitumor effect by type 2 diabetes drug, metformin","volume":"112","author":"Eikawa","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"28","key":"10.1016\/j.jsps.2021.12.014_b0075","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1038\/onc.2009.104","article-title":"Aryl hydrocarbon receptor inhibition downregulates the TGF-\u03b2\/Smad pathway in human glioblastoma cells","volume":"28","author":"Gramatzki","year":"2009","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.jsps.2021.12.014_b0080","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1517\/13543784.2013.833604","article-title":"Metformin: an old drug with new potential","volume":"22","author":"Hajjar","year":"2013","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.jsps.2021.12.014_b0085","unstructured":"Heistein, J. B. and U. Acharya, 2018. Cancer, Malignant Melanoma."},{"key":"10.1016\/j.jsps.2021.12.014_b0090","doi-asserted-by":"crossref","unstructured":"Herrera-Gayol, A., Jothy, S., 2002. Effect of hyaluronan on xenotransplanted breast cancer. Exper. Mol. Pathol.","DOI":"10.1006\/exmp.2002.2437"},{"issue":"2","key":"10.1016\/j.jsps.2021.12.014_b0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/BJ20080557","article-title":"Important role of the LKB1\u2013AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.jsps.2021.12.014_b0100","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","article-title":"Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner","volume":"11","author":"Kalender","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.jsps.2021.12.014_b0105","doi-asserted-by":"crossref","unstructured":"Kalmes, M., Hennen, J., Clemens, J., et al., 2011. Impact of aryl hydrocarbon receptor (AhR) knockdown on cell cycle progression in human HaCaT keratinocytes.","DOI":"10.1515\/bc.2011.067"},{"key":"10.1016\/j.jsps.2021.12.014_b0110","doi-asserted-by":"crossref","unstructured":"Kim, Y., Vagia, E., Viveiros, P., et al., 2021. Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC). Cancer Immunol., Immunother.","DOI":"10.1007\/s00262-020-02703-8"},{"issue":"1-3","key":"10.1016\/j.jsps.2021.12.014_b0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tox.2004.04.011","article-title":"Differential effects of mercury, lead and copper on the constitutive and inducible expression of aryl hydrocarbon receptor (AHR)-regulated genes in cultured hepatoma Hepa 1c1c7 cells","volume":"201","author":"Korashy","year":"2004","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.jsps.2021.12.014_b0120","first-page":"154","article-title":"Modulation of TCDD-mediated induction of cytochrome P450 1A1 by mercury, lead, and copper in human HepG2 cell line","volume":"22","author":"Korashy","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.jsps.2021.12.014_b0125","first-page":"1","article-title":"Camel milk triggers apoptotic signaling pathways in human hepatoma HepG2 and breast cancer MCF7 cell lines through transcriptional mechanism","volume":"2012","author":"Korashy","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"7","key":"10.1016\/j.jsps.2021.12.014_b0130","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1158\/0008-5472.CAN-13-1506","article-title":"VISTA regulates the development of protective antitumor immunity","volume":"74","author":"Le Mercier","year":"2014","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.jsps.2021.12.014_b0135","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1158\/0008-5472.CAN-13-1504","article-title":"VISTA is an immune checkpoint molecule for human T cells","volume":"74","author":"Lines","year":"2014","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.jsps.2021.12.014_b0140","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1158\/2326-6066.CIR-14-0072","article-title":"VISTA Is a Novel Broad-Spectrum Negative Checkpoint Regulator for Cancer Immunotherapy","volume":"2","author":"Lines","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jsps.2021.12.014_b0145","article-title":"Pleiotropic Effects of Metformin on the Antitumor Efficiency of Immune Checkpoint Inhibitors","volume":"11","author":"Liu","year":"2021","journal-title":"Frontiers"},{"issue":"3","key":"10.1016\/j.jsps.2021.12.014_b0150","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","article-title":"Tumor-Repopulating Cells Induce PD-1 Expression in CD8+ T Cells by Transferring Kynurenine and AhR Activation","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jsps.2021.12.014_b0155","unstructured":"Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. S1046-2023(01)91262-9 [pii]."},{"issue":"1","key":"10.1016\/j.jsps.2021.12.014_b0165","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/abbi.1995.1062","article-title":"Identification of 3\u2032-methoxy-4\u2032-nitroflavone as a pure aryl hydrocarbon (Ah) receptor antagonist and evidence for more than one form of the nuclear Ah receptor in MCF-7 human breast cancer cells","volume":"316","author":"Lu","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.jsps.2021.12.014_b0170","doi-asserted-by":"crossref","first-page":"e12557","DOI":"10.1111\/jpi.12557","article-title":"Pan-cancer genomic analyses reveal prognostic and immunogenic features of the tumor melatonergic microenvironment across 14 solid cancer types","volume":"66","author":"Lv","year":"2019","journal-title":"J. Pineal Res."},{"issue":"2","key":"10.1016\/j.jsps.2021.12.014_b0175","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.taap.2015.02.007","article-title":"Metformin inhibits 7, 12-dimethylbenz [a] anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1\/aryl hydrocarbon receptor signaling pathway","volume":"284","author":"Maayah","year":"2015","journal-title":"Toxicol. Appl."},{"issue":"10","key":"10.1016\/j.jsps.2021.12.014_b0180","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1021\/es062793g","article-title":"Aryl Hydrocarbon Receptor Plays a Significant Role in Mediating Airborne Particulate-Induced Carcinogenesis in Mice","volume":"41","author":"Matsumoto","year":"2007","journal-title":"Environ. Sci. Technol."},{"issue":"8","key":"10.1016\/j.jsps.2021.12.014_b0185","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1158\/0008-5472.CAN-06-3822","article-title":"Specific growth rate versus doubling time for quantitative characterization of tumor growth rate","volume":"67","author":"Mehrara","year":"2007","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jsps.2021.12.014_b0190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Miller","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jsps.2021.12.014_b0195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41379-019-0364-z","article-title":"V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma","volume":"33","author":"Muller","year":"2020","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.jsps.2021.12.014_b0200","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1124\/mol.110.069369","article-title":"Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3\u2032, 4\u2032-dimethoxy-\u03b1-naphthoflavone","volume":"79","author":"Murray","year":"2011","journal-title":"Molecular"},{"key":"10.1016\/j.jsps.2021.12.014_b0205","series-title":"Guide laboratory animals for the care and use of. Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research Division on Earth and Life Studies","author":"Nih","year":"2011"},{"key":"10.1016\/j.jsps.2021.12.014_b0210","doi-asserted-by":"crossref","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jsps.2021.12.014_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9610(78)90171-X","article-title":"Metastatic pattern of malignant melanoma: a study of 216 autopsy cases","author":"Patel","year":"1978","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.jsps.2021.12.014_b0220","doi-asserted-by":"crossref","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin\u2014mode of action and clinical implications for diabetes and cancer","author":"Pernicova","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jsps.2021.12.014_b0225","doi-asserted-by":"crossref","unstructured":"Pilotte, L., Larrieu, P., Stroobant, V., et al., 2012. Reversal of tumoral immune resistance by inhibition of tryptophan 2, 3-dioxygenase. Proc. Natl. Acad. Sci.","DOI":"10.1073\/pnas.1113873109"},{"key":"10.1016\/j.jsps.2021.12.014_b0230","doi-asserted-by":"crossref","DOI":"10.4161\/onci.19071","article-title":"The aryl hydrocarbon receptor in tumor immunity","author":"Platten","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jsps.2021.12.014_b0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-018-0160-1","article-title":"The AHR represses nucleotide excision repair and apoptosis and contributes to UV-induced skin carcinogenesis","author":"Pollet","year":"2018","journal-title":"Cell Death & Different."},{"key":"10.1016\/j.jsps.2021.12.014_b0240","doi-asserted-by":"crossref","DOI":"10.1038\/nri2163","article-title":"IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation","author":"Puccetti","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jsps.2021.12.014_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.12.036","article-title":"FOXD3 regulates VISTA expression in melanoma","author":"Rosenbaum","year":"2020","journal-title":"Cell reports."},{"key":"10.1016\/j.jsps.2021.12.014_b0250","article-title":"alpha-Naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation","author":"Santostefano","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jsps.2021.12.014_b0255","doi-asserted-by":"crossref","unstructured":"Scharping, N.E., Menk, A.V., Whetstone, R.D., et al., 2017. Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia. Cancer Immunol. Res.","DOI":"10.1158\/2326-6066.CIR-16-0103"},{"key":"10.1016\/j.jsps.2021.12.014_b0260","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1097-0320(19981001)33:2<179::AID-CYTO12>3.0.CO;2-R","article-title":"Quantitative fluorescence flow cytometry: a comparison of the three techniques for direct and indirect immunofluorescence","author":"Serke","year":"1998","journal-title":"Cytometry"},{"key":"10.1016\/j.jsps.2021.12.014_b0265","article-title":"Cancer treatment and survivorship statistics, 2012","author":"Siegel","year":"2012","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jsps.2021.12.014_b0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125779","article-title":"Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells","author":"Tanaka","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jsps.2021.12.014_b0275","doi-asserted-by":"crossref","DOI":"10.7150\/thno.33595","article-title":"QuatCy: a heptamethine cyanine modification with improved characteristics","author":"Thavornpradit","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jsps.2021.12.014_b0280","doi-asserted-by":"crossref","unstructured":"Volm, M., Koom\u00e4gi, R., Mattern, J., 1997. Prognostic value of vascular endothelial growth factor and its receptor Flt\u20101 in squamous cell lung cancer. Int. J. Cancer.","DOI":"10.1002\/(SICI)1097-0215(19970220)74:1<64::AID-IJC11>3.0.CO;2-I"},{"key":"10.1016\/j.jsps.2021.12.014_b0285","article-title":"The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jsps.2021.12.014_b0290","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/269756","article-title":"Coinhibitory molecules in autoimmune diseases","author":"Watanabe","year":"2012","journal-title":"Clin. Develop. Immunol."},{"key":"10.1016\/j.jsps.2021.12.014_b0295","article-title":"The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer","author":"Xie","year":"2020","journal-title":"Frontiers"},{"key":"10.1016\/j.jsps.2021.12.014_b0300","doi-asserted-by":"crossref","DOI":"10.1111\/j.1440-1681.2007.04601.x","article-title":"Optimizing dosage of ketamine and xylazine in murine echocardiography","author":"Xu","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.jsps.2021.12.014_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.658488","article-title":"Terminating Cancer by Blocking VISTA as a Novel Immunotherapy: Hasta la vista, baby","author":"Yum","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.jsps.2021.12.014_b0310","article-title":"Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression","author":"Zhang","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.jsps.2021.12.014_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/S0003-9861(03)00274-1","article-title":"3\u2032-methoxy-4\u2032-nitroflavone, a reported aryl hydrocarbon receptor antagonist, enhances Cyp1a1 transcription by a dioxin responsive element-dependent mechanism","author":"Zhou","year":"2003","journal-title":"Arch. Biochem. Biophys."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016421002632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016421002632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T12:27:09Z","timestamp":1736166429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016421002632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1319016421002632"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2021.12.014","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin attenuates V-domain Ig suppressor of T-cell activation through the aryl hydrocarbon receptor pathway in Melanoma: In Vivo and In Vitro Studies","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2021.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}